BLRX Share Price

Open 0.90 Change Price %
High 0.93 1 Day 0.00 0.00
Low 0.90 1 Week 0.02 2.27
Close 0.90 1 Month -0.08 -8.16
Volume 62184 1 Year -0.06 -6.25
52 Week High 1.42
52 Week Low 0.00
BLRX Important Levels
Resistance 2 0.93
Resistance 1 0.92
Pivot 0.91
Support 1 0.88
Support 2 0.87
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
DRYS 1.87 0.00%
ACAS 17.99 0.39%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
LINE 0.18 12.50%
ATEA 1.90 11.76%
ATEA 1.90 11.76%
KITD 0.30 11.11%
SGYPU 10.75 10.26%
LPHI 0.24 9.09%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

BioLineRx Ltd. (NASDAQ: BLRX)

BLRX Technical Analysis 4
As on 13th Jan 2017 BLRX Share Price closed @ 0.90 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.96 & Strong Sell for SHORT-TERM with Stoploss of 1.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
BLRX Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BioLineRx Ltd. ( NASDAQ USA Symbol : BLRX )
Sector : N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company And Other Stocks in Same Sector
BLRX
0.90 0.00 (0.00 %)
LT : Sell
ST : Strong Sell
BLRX Other Details
Segment EQ
Market Capital 52288676.00
Sector N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company
Industry N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical de
Offical website http://www.biolinerx.com
BLRX Address
BLRX
19 Hartum Street
PO Box 45158
Jerusalem, 91450
Israel
Phone: 972 2 548 9100
Fax: 972 2 548 9101
BLRX Latest News
Interactive Technical Analysis Chart BioLineRx Ltd. ( BLRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioLineRx Ltd.
BLRX Business Profile
BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications. More from Reuters »